Microwave Assisted Synthesis of 4-Phenylquinazolin-2(1H)-one Derivatives that Inhibit Vasopressor Tonus in Rat Thoracic Aorta

被引:4
作者
Teixeira, Rafaela [1 ]
Menengat, Talita [2 ]
Andrade, Gabriel [3 ]
Cotrim, Bruno [3 ]
Ponte, Cristiano [2 ]
Santos, Wilson C. [1 ]
Resende, Gabriel [3 ]
机构
[1] Univ Fed Fluminense, Programa Posgrad Ciencias Aplicadas & Prod Saude, Fac Farm, Niteroi 24241000, RJ, Brazil
[2] Inst Fed Rio De Janeiro, Nucleo Ciencia Biomed Aplicadas, Rio De Janeiro 20270021, RJ, Brazil
[3] Inst Fed Rio De Janeiro, Nucleo Ciencias Quim, Rio De Janeiro 20270021, RJ, Brazil
来源
MOLECULES | 2020年 / 25卷 / 06期
关键词
microwave irradiation; 4-phenylquinazolin-2(1H)-one; vasorelaxation; endothelium; rat thoracic aorta; BIOLOGICAL EVALUATION; QUINAZOLINONE; DISCOVERY; SCAFFOLDS; DESIGN;
D O I
10.3390/molecules25061467
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinazolinones have pharmacological effects on vascular reactivity through different mechanisms. We synthesized 4-phenylquinazolin-2(1H)-one derivatives under microwave irradiation and tested them on the rat thoracic aorta. The prepared compounds 2a-2f were obtained in about 1 h with suitable yields (31-92%). All derivatives produced vasorelaxant effects with IC50 values ranging from 3.41 +/- 0.65 mu M to 39.72 +/- 6.77 mu M. Compounds 2c, 2e and 2f demonstrated the highest potency in endothelium-intact aorta rings (IC50 4.31 +/- 0.90 mu M, 4.94 +/- 1.21 mu M and 3.41 +/- 0.65 mu M respectively), and they achieved around 90% relaxation (30 mu M). In aorta rings without an endothelium, the effect of compound 2f was abolished. Using the MTT assay to test for cell viability, only compound 2b induced cytotoxicity at the maximum concentration employed (30 mu M). The results show that vasorelaxation by 4-phenylquinazolin-2(1H)-one derivatives might depend on the activation of a signalling pathway triggered by endothelium-derived factors.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] Synthesis and anticancer activity of new quinazoline derivatives
    Abuelizz, Hatem A.
    Marzouk, Mohamed
    Ghabbour, Hazem
    Al-Salahi, Rashad
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (07) : 1047 - 1054
  • [2] An overview of quinazolines: Pharmacological significance and recent developments
    Alagarsamy, V.
    Chitra, K.
    Saravanan, G.
    Solomon, V. Raja
    Sulthana, M. T.
    Narendhar, B.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 628 - 685
  • [3] Discovery of 4,4-Disubstituted Ouinazolin-2-ones as T-Type Calcium Channel Antagonists
    Barrow, James C.
    Rittle, Kenneth E.
    Reger, Thomas S.
    Yang, Zhi-Qiang
    Bondiskey, Phung
    McGaughey, Georgia B.
    Bock, Mark G.
    Hartman, George D.
    Tang, Cuyue
    Ballard, Jeanine
    Kuo, Yuhsin
    Prueksaritanont, Thomayant
    Nuss, Cindy E.
    Doran, Scott M.
    Fox, Steven V.
    Garson, Susan L.
    Kraus, Richard L.
    Li, Yuxing
    Marino, Michael J.
    Graufelds, Valerie Kuzmick
    Uebele, Victor N.
    Renger, John J.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (02): : 75 - 79
  • [4] Synthesis of Dimeric Quinazolin-2-one, 1,4-Benzodiazepin-2-one, and Isoalloxazine Compounds as Inhibitors of Amyloid Peptides Association
    Barthel, Alexander
    Trieschmann, Lothar
    Stroehl, Dieter
    Kluge, Ralph
    Boehm, Gerald
    Csuk, Rene
    [J]. ARCHIV DER PHARMAZIE, 2009, 342 (08) : 445 - 452
  • [5] Convergent assembly of structurally diverse quinazolines
    Crespo, Abel
    Coelho, Alberto
    Diz, Paula M.
    Fernandez, Franco
    de Armas, Hector Novoa
    Sotelo, Eddy
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2011, 9 (02) : 351 - 357
  • [6] Synthesis, biological evaluation and molecular modeling study of some new methoxylated 2-benzylthio-quinazoline-4(3H)-ones as nonclassical antifolates
    El-Messery, Shahenda M.
    Hassan, Ghada S.
    Nagi, Mahmoud N.
    Habib, El-Sayed E.
    Al-Rashood, Sarah T.
    El-Subbagh, Hussein I.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4815 - 4823
  • [7] NO: the primary EDRF
    Fleming, I
    Busse, R
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (01) : 5 - 14
  • [8] 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads
    Gatadi, Srikanth
    Lakshmi, T. Vasanta
    Nanduri, Srinivas
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 170 : 157 - 172
  • [9] Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016)
    Hameed, Abdul
    Al-Rashida, Mariya
    Uroos, Maliha
    Ali, Syed Abid
    Arshia
    Ishtiaq, Marium
    Khan, Khalid Mohammed
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (04) : 281 - 297
  • [10] Recent advances in selective α1-adrenoreceptor antagonists as antihypertensive agents
    Jain, Kishor S.
    Bariwal, Jitender B.
    Kathiravan, Muthu K.
    Phoujdar, Manisha S.
    Sahne, Rajkumari S.
    Chauhan, Bishram S.
    Shah, Anamik K.
    Yadav, Mange Ram
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (09) : 4759 - 4800